Restasis - Dosage - Side Effects - Drug Interactions - Warnings
Restasis (cyclosporine opthalmalic emulsion) drug information, dosage, side effects, drug interactions, and warnings. Restasis, generic drug name cyclosporine opthalmalic emulsion, is a medication used to treat chronic dry eye symptoms in conditions such as Sjogren's syndrome, keratoconjunctivitis sicca, and dry eye syndrome.
Patient Education: Restasis / Cyclosporine Ophthalmic Emulsion
Patient education for Restasis / cyclosporine ophthalmic emulsion.
Dry Eyes - Guide to Dry Eyes
When the eyes don't produce enough tears or the right quality of tears, the result is a condition called keratitis sicca, popularly known as "dry eyes." Autoimmune diseases, such as lupus, rheumatoid arthritis, and Sjögren's syndrome, are among the many causes of dry eyes.
Guide to Sjogren's Syndrome
Sjogren's syndrome is an autoimmune disease. In Sjogren's syndrome, the immune system targets moisture-producing glands and causes dryness in the mouth and eyes. Other parts of the body can be affected as well, resulting in a wide range of possible symptoms.
Sjogren's Syndrome Screening Quiz
Sjogren's syndrome can occur as a primary condition or a secondary condition. Take our screening quiz and see if you have symptoms associated with Sjogren's syndrome.
Restasis (Cyclosporine Ophthalmic Emulsion)
Restasis (cyclosporine ophthalmic emulsion) is a FDA-approved prescription eye drop. It is the only prescription eye drop for this condition that helps your eyes increase their own tear production with continued use, from Allergan, Inc.
Drug Profile: Restasis
Drug profile and essential information for Restasis, from PDRHealth.
Newly Approved Drug Therapies: Restasis (Cyclosporine Ophthalmic)
Restasis (cyclosporine ophthalmic emulsion) is a topical formulation indicated for the treatment of reduced tear production due to inflammation from dry eye disease. While the routine, daily use of artificial tears provides symptomatic relief, Restasis helps fight the cause of the condition, from CenterWatch.
